Alexandre Detappe
Alexandre Detappe
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Harvard Medical School, Boston, MA USA
3Institut de Cancérologie Strasbourg Europe, Strasbourg, France
1,2,3,#,
Hung V-T Nguyen
Hung V-T Nguyen
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Harvard Medical School, Boston, MA USA
4Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA USA
5Window Therapeutics, Boston, MA USA
1,2,4,5,#,
Yivan Jiang
Yivan Jiang
4Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA USA
5Window Therapeutics, Boston, MA USA
4,5,
Michael P Agius
Michael P Agius
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Harvard Medical School, Boston, MA USA
1,2,
Wencong Wang
Wencong Wang
4Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA USA
4,
Clelia Mathieu
Clelia Mathieu
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Harvard Medical School, Boston, MA USA
1,2,
Nang K Su
Nang K Su
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Harvard Medical School, Boston, MA USA
1,2,
Samantha L Kristufek
Samantha L Kristufek
4Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA USA
4,
David J Lundberg
David J Lundberg
6Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
6,
Sachin Bhagchandani
Sachin Bhagchandani
6Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
6,
Irene M Ghobrial
Irene M Ghobrial
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Harvard Medical School, Boston, MA USA
1,2,✉,
P Peter Ghoroghchian
P Peter Ghoroghchian
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Harvard Medical School, Boston, MA USA
1,2,✉,
Jeremiah A Johnson
Jeremiah A Johnson
4Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA USA
7Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
8Broad Institute of MIT and Harvard, Cambridge, MA USA
4,7,8,✉
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Harvard Medical School, Boston, MA USA
3Institut de Cancérologie Strasbourg Europe, Strasbourg, France
4Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA USA
5Window Therapeutics, Boston, MA USA
6Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
7Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA
8Broad Institute of MIT and Harvard, Cambridge, MA USA
Subject terms: Drug delivery, Nanotechnology in cancer
© The Author(s), under exclusive licence to Springer Nature Limited 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
